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Background: Diagnosis of extrapulmonary tuberculosis continues to be a challenge due to the
complexity of the causative organism and the wide array of pathologic features seen in this
infection. Xpert MTB/RIF can be used on fresh or frozen tissue specimens for diagnosis of
tuberculosis with good results. However, there is little data on its use with formalin-fixed
paraffin-embedded (FFPE) tissues.
Objectives: The aim of this study was to demonstrate the potential utility of Xpert MTB/RIF
and to compare its performance to Ziehl-Neelsen staining for the detection of Mycobacterium
tuberculosis from FFPE tissues using histological features from haematoxylin and eosin staining
as the gold standard.
Methods: Eighty randomly selected archival FFPE tissues exhibiting histological features of
tuberculosis were included in the study. After deparaffinisation and lysis, all the tissue
specimens were subjected to the Xpert® MTB/RIF assay. The outcome measures were
proportions of positively identified cases by each test.
Results: Using histology as the gold standard, the sensitivity of Ziehl-Neelsen staining was
20.3% (95% confidence interval: 12% – 30.8%), and the sensitivity of the Xpert® MTB/RIF assay
was 53.2% (95% confidence interval: 41.6% – 64.9%); the difference was statistically significant
(p = 0.002). None of the cases tested positive for rifampicin resistance.
Conclusion: With prior deparaffinisation and lysis, FFPE tissues are amenable to testing by
Xpert® MTB/RIF assay. A validation study to determine the clinical utility, analytical
optimisation and cost implications of this assay for FFPE tissues is recommended.
Keywords: Xpert MTB/RIF; extrapulmonary tuberculosis; formalin-fixed paraffin-embedded
tissues; Kenya.

Introduction
Globally, extrapulmonary tuberculosis (EPTB) represented 15% of the 6.3 million cases and in
Africa 16% of the 1.2 million cases that were notified in 2016. Children and the
immunosuppressed population have been reported to be at a higher risk of EPTB than the
general population.1,2
Diagnosis of EPTB involves analysis of fresh or fixed tissue biopsies using culture, histological
examination or molecular tests. Culture is regarded as the gold standard; however, its main
disadvantages are the long turnaround time – up to 6 weeks – and the fact that only fresh tissue
can be used. In addition, the sensitivity of cultures has been found to be variable (0% – 80%).3
Histological diagnosis of tuberculosis on haematoxylin and eosin (H&E) stained sections
usually relies on the presence of classical necrotising granulomas with Langhans giant cells.
However, tuberculosis can exhibit other patterns of inflammation such as non-necrotising
granulomatous inflammation, non-specific chronic inflammatory processes and suppurative
inflammation.3,4,5 In HIV and tuberculosis co-infection for example, there may be both delay and
poor or no formation of granulomas.6 In addition, other agents and pathologic conditions can
mimic tuberculosis. Examples include infections caused by nontuberculous mycobacteria,
bacteria other than mycobacteria, fungi, some viruses and parasites as well as non-infective
causes such as Vasculitides and Crohn’s disease.7,8 Presence of acid-fast bacilli (AFB) on ZiehlNeelsen (ZN) staining is widely utilised as a confirmatory test for EPTB in a wide spectrum of
formalin fixed paraffin embedded (FFPE) tissues because it is quick and relatively cheap;
however, its drawback is its low sensitivity (40%).3,9,10
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Both commercial and in-house polymerase chain reaction
(PCR) based assays for tuberculosis have been used to
improve detection rates of EPTB in FFPE tissues and to
overcome some of the limitations encountered by the
aforementioned tests.11,12 Polymerase chain reaction based
assays have been found to be more powerful in ruling in
rather than ruling out a diagnosis of tuberculosis.10 A major
reason for this is the fact that most EPTB tissue specimens
tend to be paucibacillary. Moreover, the bacilli are usually not
uniformly distributed throughout the specimens.12,13,14
The Xpert® MTB/RIF assay (Cepheid, Sunnyvale, California,
United States) is an automated semi-nested real time PCR
in which sample lysis, DNA extraction, amplification and
detection takes place within a single plastic cartridge. The
assay detects the presence of the M. tuberculosis complex and
rifampicin resistance within 2 hours.15,16 The World Health
Organization initially endorsed the assay in 2010 as a rapid
nucleic acid amplification assay that simultaneously detects
the presence of the M. tuberculosis complex and rifampicin
resistance in sputa. However, a wide spectrum of tissues are
now being analysed using the Xpert® MTB/RIF assay.17,18
Meta-analysis done on the accuracy of Xpert MTB/RIF in
detecting tuberculosis shows that the median pooled
sensitivity and specificity in lymph nodes was 84.9% and
92.5%, while in tissues other than lymph nodes, the median
pooled sensitivity and specificity was 81.2% and 98.1%.19 In
these studies, the nature of the specimens was reported to be
either fresh or frozen. A Zambian study published in 2017
by Polepole et al. showed Xpert® MTB/RIF assay to be
potentially useful for the diagnosis of tuberculosis in FFPE
tissues. However, the sensitivity was found to be too low.
Using histology as the gold standard, the accuracy of
ZN, Xpert MTB/RIF, and in-house PCR were assessed in
100 FFPE tissues. The sensitivity of Xpert MTB/RIF
within lymph nodes and non-lymph node tissues was 30%
and 35%.20
When dealing with FFPE tissues as the starting specimen
on PCR based assays, pretreatment procedures for
deparaffinisation and mitigation of the effects of PCR
inhibitors is necessary.21,22,23,24 On the other hand, only
minimal bio-safety requirements are needed for FFPE tissues
since they do not contain live bacilli. The Xpert MTB/RIF
platform, when compared to other PCR platforms, offers
additional benefits that include ease of conducting the test
and interpreting the results. In addition, only minimal time is
required to train laboratory staff who can operate the
system.16,18 The Xpert MTB/RIF technology is also widely
available and accessible as opposed to the other technologies
that tend to be found mainly in reference laboratories.
On many occasions, tissues are submitted to the laboratory
while fixed in formalin and with no possibility of culture. The
low sensitivity of ZN often results in negative ZN staining.
Not infrequently, tissues also lack the typical histologic
features of tuberculosis. In these situations, Xpert MTB/RIF
can be a useful adjunct or ‘add-on’ test for EPTB.
http://www.ajlmonline.org
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Methods

Ethical considerations
The Health Research Ethics Committee, Aga Khan University,
provided approval for the study [2014/REC-56(v3)].

Study design and setting
This was a retrospective cross-sectional laboratory based
study conducted at the Aga Khan University Hospital,
Nairobi, in the department of Pathology and Laboratory
Medicine. The laboratory receives samples from the
university hospital as well as from other county and mission
hospitals within the country. Only 17% of the samples
analysed in this study were from the university hospital and
these were fixed in 10% neutral buffered formalin for 6–12 h
prior to processing. The remaining 83% were from the other
hospitals and the dilution of formalin used and duration of
fixation could not be determined. The patient’s biodata, site
of biopsy and relevant clinical history, when provided, were
obtained from the laboratory specimen inventory and
information system.

Sampling
The study included specimens received between January and
December 2014 and with a diagnosis of EPTB based on the
original histology features from H&E staining (necrotising
granulomatous inflammation, non-necrotising granulomatous
inflammation, chronic inflammation, necrotising inflammation
or suppurative inflammation). The specimens were included
irrespective of their ZN results; however, specimens in which
a diagnosis of EPTB had been ruled out, such as cases of fungal
infection, were not considered. Out of the 132 archived FFPE
tissue blocks that fit the above description, 17 were excluded
because the amount of tissue preserved was too small to
produce an adequate sample for H&E staining, ZN staining
and the Xpert® MTB/RIF assay. Out of the 115 remaining
blocks, 80 FFPE blocks were randomly selected for analysis.

Laboratory procedures
From each FFPE block, H&E and ZN stained slides were
prepared on 3 µm thick sections. The histological pattern of
inflammation for each case was recorded. The ZN stained
slides were screened for AFB under oil at ×1000 magnification
and the results recorded as either positive or negative. The
principal investigator first screened all the slides and then
every fifth case had the H&E and ZN stained slide screened
by a second pathologist. For the Xpert® MTB/RIF assay, up to
10 sections of 10 µm thickness were cut from the FFPE blocks
and the scrolls placed in a 1.5 mL micro-centrifuge tube.
Deparaffinisation was done using a modified xylene method,
which involved two washes in 1 mL of xylene, two washes in
1 mL of absolute ethanol followed by two rinses in 1 mL of
phosphate buffered saline. Lysis of the tissue fragments
followed with resuspension of the tissue fragments in 1 mL
of phosphate buffered saline and the addition of 20 µL of
QIAGEN proteinase K, then the mixture was incubated at
Open Access
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56 °C for 12 hours. If there were tissue fragments visible on
inspection after the initial incubation, another 20 µL of
proteinase K was added and re-incubated for 1 or 2 h. After
complete lysis was achieved, the proteinase K was deactivated
by increasing the temperature to 94 °C for 10 min.25 The
Xpert® MTB/RIF assay was then performed following the
manufacturer’s instructions using the lysate and without any
further attempt to extract DNA from the lysate. As a quality
control measure, the microtome blade was changed and the
microtome overlay cleaned with absolute alcohol after each
case to prevent carryover contamination.6,20,21
Xpert MTB/RIF results were recorded as either detected, not
detected or error. One case resulted in an Xpert® MTB/RIF
assay error. The bacilli load in each specimen was also
recorded following the assay’s semi-quantitative estimate of
the bacilli load as either high, medium, low or very low.
Rifampicin resistance was recorded as either detected, not
detected or indeterminate.15

Data analysis
The data were analysed using the Statistical Package for
Social Sciences version 19, (IBM Corp, Armonk, New York,
United States). Sensitivities were calculated from proportions
of cases positive on Xpert MTB/RIF and those positively
detected by ZN against histology as the gold standard. A Chisquare test was applied to test for statistical differences and p
values less than 0.05 were considered statistically significant.

Results
Only 79 cases were analysed after the single case without
Xpert MTB/RIF results was excluded from further analysis.
TABLE 1: Demographic and topographic sites of tissues.
Characteristic

Value (n = 79)
n

%

27 (6–85)

-

Male

35

44.3

Female

44

55.7

Lymph nodes

30

38.0

Female genital tract

15

19.0

Abdominal tissues

11

13.9

Soft tissues

9

11.4

Joint tissues

6

7.6

Pleura and pericardium

4

5.1

Bone

2

2.5

Central nervous system

1

1.3

Male genital tract

1

1.3

Age
Mean (range)
Sex

Topographic sites of tissues
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The mean age of patients was 27 years with an age range of 6
to 85 years. Forty-four (55.7%) specimens were from female
patients, and 35 (44.3%) were from male patients. Twentysix different types of tissues were analysed and classified
into nine groups according to the topographic site of the
biopsy (Table 1). Lymph nodes were the most common
site, 30 specimens (38%), followed by the female genital
tract, 15 specimens (19%), and the abdominal cavity,
11 specimens (13.9%). The least prevalent sites were the
male genital tract and the central nervous system with
only one specimen each. Clinical information was available
for 48.1% (38/79) of the specimens, of which 13.2% (5/38)
were reported to have confirmed tuberculosis in a site
other than the tissue submitted. Xpert MTB/RIF was
positive for all five specimens, and ZN was positive for
three of the five specimens. In 36.8% (14/38) of the
specimens with clinical information, tuberculosis was
clinically suspected; 5 out of the 14 were positive by Xpert
MTB/RIF and 1 by ZN. HIV infection was reported in six
(15.8%) of the specimens, of which four were positive by
Xpert MTB/RIF and two by ZN.
Necrotising granulomatous inflammation was the
predominant histological pattern of inflammation contributing
to 91.1% (72/79) of the specimens (Table 2). In this group, 53%
(38/72) were positive by Xpert MTB/RIF and 22% (16/72) by
ZN. The contribution of granulomatous inflammation, chronic
inflammation, necrotising inflammation and suppurative
inflammation was marginal. In this latter group of inflammation
combined, 57% (4/7) were positive by Xpert MTB/RIF and
none by ZN.
In lymph node tissues, 16 out of 30 were positive by Xpert
MTB/RIF compared to 8 by ZN, whereas in non-lymph node
tissues, 26 of 49 were positive by Xpert MTB/RIF compared
to 8 by ZN (Table 3). Xpert MTB/RIF was positive in 87.5%
(14/16) of the specimens that were ZN positive. Two
specimens that were ZN-positive gave a negative Xpert
MTB/RIF result. Using H&E histology results as the gold
standard, the overall sensitivity of ZN was 20.3% (95%
confidence interval [CI]: 12% – 30.8%) and that of Xpert
MTB/RIF was 53.2% (95% CI: 41.6% – 64.9%), significantly
better than ZN (p = 0.002).
Of the 42 Xpert MTB/RIF positive specimens, the bacilli load
in 26 (61.9%) was quantified as ‘very low’, 11 (26.2%) as ‘low’
and only 5 (11.9%) as ‘medium’. None of the cases showed a
‘high’ bacilli load and neither was there any case of rifampicin
resistance detected. However, 7 of the 42 Xpert MTB/RIFpositive cases showed an ‘indeterminate’ rifampicin
resistance, all of which had a ‘very low’ bacilli load.

TABLE 2: Yield of Ziehl-Neelsen and Xpert MTB/RIF by patterns of inflammation.
Histologic pattern

Ziehl-Neelsen staining
Negative

Xpert MTB/RIF

Positive

Negative

Positive

n

%

N

%

N

%

n

%

Necrotising granulomatous inflammation (n = 72)

56

78

16

22

34

47

38

53

Others (n = 7)†

7

100

0

-

3

43

4

57

†, Granulomatous, n = 3; Chronic, n = 2; Necrotising, n = 1; Suppurative, n = 1.
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TABLE 3: Yield of Ziehl-Neelsen and Xpert MTB/RIF test by tissue type.
Tissue t

Ziehl-Neelsen staining

Xpert MTB/RIF

Negative

Positive

Sensitivity (CI)

Negative

Positive

Sensitivity (CI)

Lymph node tissues

22

8

26.7 (13–46.2)

14

16

53.3 (34.6–71.2)

Non-lymph node tissues

41

8

16.3 (7.8–30.2)

23

26

53.1 (38.4–67.2)

-

-

20.3 (12–30.8)

-

-

53.2 (41.6–64.9)

Overall sensitivity
CI, confidence interval.

Discussion
In this study, we compared the Xpert MTB/RIF assay to
histology for the detection of M. tuberculosis from archived
FFPE tissues. The results obtained show that Xpert MTB/RIF
had a higher sensitivity (53.2%) than ZN (20.3%). Similar to
other studies, we found that ZN had a low sensitivity for
tuberculosis in FFPE tissues.3 The sensitivity of Xpert MTB/
RIF in our study was comparable to, though slightly higher
(53.2% vs 50%) than, a previous study, in which the
performance of the QIAGEN artus M. tuberculosis RG PCR
assay was compared to Xpert MTB/RIF among 40 FFPE
tissues with histopathological features consistent with
tuberculosis.26 Similarly, the sensitivity of Xpert MTB/RIF in
our study for lymph node and non-lymph node specimens
(53.1% and 53.1%) was higher than that found by Polepole et
al. (30% and 35%).20 In further support of the usefulness of
Xpert MTB/RIF, its performance was found to be better than
ZN in specimens from patients reported to have tuberculosis
in other sites and HIV infection.
In this study, we could not determine the specificity of Xpert
MTB/RIF, because we only included tissues with histological
features of tuberculosis. The two cases that were ZN positive
and Xpert MTB/RIF negative may represent false negatives
or may have been cases of nontuberculous mycobateria. We
could however not confirm the true status, because culture
was not performed. Another possible explanation is that
cases of EPTB tend to be paucibacillary. Moreover, the bacilli
may not be evenly distributed within the tissue,3 raising the
possibility that the sample came from a part of the tissue that
may have not harboured any organisms. Multiple (up to 10
sections, 10 µm thick) sections of tissue were processed for
Xpert MTB/RIF testing with the aim of increasing the chances
of obtaining sections with the bacilli; however, we do not
know to what extent this mitigated the above factors.
The quality of DNA is also likely to have been reduced due to
the untoward effects of formalin fixation.22 A study by
Jonathan et al. conducted to investigate the effects of fixatives
and fixation times on PCR showed that formalin-fixed tissues
gave reliable PCR results, if the tissue was fixed for less than
48 h.23 In this study, standardisation of fixation times and
dilution of formalin used could not be determined for 83%
of the specimens that had been referred from other hospitals
in different parts of the country.
A semi-quantitative estimate of bacilli load based on the cycle
threshold value is another parameter that is obtained from
the Xpert® MTB/RIF assay. In this study, we found that more
than three-quarters of the cases (61.9% and 26.2%) had a
http://www.ajlmonline.org

quantification of either ‘very low’ or ‘low’. This finding is
probably due to the above-mentioned pre-analytical factors:
the paucibacillary nature of EPTB samples and formalin
fixation.
The secondary objective of our study was to determine the
prevalence of rifampicin resistance. In this study, no case of
rifampicin resistance was detected. Indeterminate rifampicin
resistance results were however obtained for seven of the
42 cases positive on Xpert MTB/RIF. Not surprisingly, all had
a very low bacilli load. Therefore, only in the 35 cases with
rifampicin resistance results could we truly say that there
was no case of rifampicin resistance detected. In the study by
Polepole et al., a similar problem of a large number of
‘indeterminate’ results for rifampicin resistance was also
encountered. Therefore, a very low bacilli load as quantified
by Xpert MTB/RIF, which subsequently limits the assessment
of rifampicin resistance, may have led to this finding. It is
also likely that this finding was due to the small sample size
of this study.

Limitations
This study was limited by its small sample size and its
retrospective nature. The duration of fixation and the
strength of the formalin used were not known for the
majority of the specimens. These are important factors,
because they affect the quality of the DNA extracted. Lack
of culture results and additional clinical information are
additional limitations, because they would have aided in
the determination of the clinical utility of this assay in the
context of FFPE tissues.

Conclusion
Histological assessment of H&E and ZN stained slides
forms a readily accessible and affordable diagnostic tool for
EPTB. However, the inability to make a definitive diagnosis
of EPTB is common due to its low sensitivity. In our study,
we found that culture for EPTB was rarely done and all the
samples we analysed were received in the laboratory
already fixed in formalin, thereby precluding culture as a
diagnostic test. Since the Xpert MTB/RIF assay is widely
available in many parts of Kenya, it may potentially be an
excellent ‘add-on’ or adjunct test for the detection of
M. tuberculosis in fixed tissues. This is especially true in
cases that are ZN-negative or those that lack the typical
histologic features of tuberculosis. We recommend a
validation study to determine the clinical utility, analytical
optimisation and cost implications of this assay.
Open Access
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